Free Trial

OncoCyte (OCX) Earnings Date, Estimates & Call Transcripts

OncoCyte logo
$2.84 +0.01 (+0.35%)
Closing price 04/17/2025 03:56 PM Eastern
Extended Trading
$2.84 0.00 (0.00%)
As of 04/17/2025 04:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

OncoCyte Earnings Summary

Upcoming
Earnings Date
May. 13After Market ClosesEstimated
Consensus EPS
(Mar. 24)
-$0.40
Actual EPS
(Mar. 24)
$0.48 Beat By $0.88
Actual Revenue
(Mar. 24)
$1.49M

OncoCyte issued Q4 2024 earnings on March 24, 2025, reporting an EPS of $0.48, which topped analysts' consensus estimates of -$0.40 by $0.88. Quarterly revenue was reported to be $1.49 million, above analyst estimates of $0.16 million. With a trailing EPS of -$4.40, OncoCyte's earnings are expected to grow next year, from ($2.57) to ($1.40) per share.

Q4 2024 Earnings Resources

OCX Upcoming Earnings

OncoCyte's next earnings date is estimated for Tuesday, May 13, 2025, based on past reporting schedules.

Get OncoCyte Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on OncoCyte and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

OCX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

OCX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

OncoCyte Analyst EPS Estimates

Current Year EPS Consensus Estimate
($2.57) EPS
Next Year EPS Consensus Estimate
($1.40) EPS

OncoCyte Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/13/2025
(Estimated)
--------
3/24/2025Q4 2024-$0.40$0.48+$0.88-$1.93$0.16M$1.49M
11/12/2024Q3 2024-$0.44-$0.98 -$0.54-$0.98-$0.12M
8/8/2024Q2 2024--$0.36 -$0.36-$0.36-$0.10M
5/15/2024Q1 2024--$1.13 -$1.13-$1.13-$0.18M
11/9/2023Q3 2023-$1.52-$0.57+$0.95-$0.33$0.40M$0.43M
8/10/2023Q2 2023-$2.60-$1.07+$1.53-$1.07$0.60M$0.46M
5/11/2023Q1 2023-$2.40-$0.80+$1.60-$2.00$0.50M$0.30M
5/11/2023Q1 2023-$2.40-$0.80+$1.60-$2.00$0.50M$0.30M
5/11/2023Q1 2023-$2.40-$0.80+$1.60-$2.00$0.50M$0.30M
5/11/2023Q1 2023-$2.40-$0.80+$1.60-$0.10$0.50M$0.30M
5/11/2023Q1 2023-$2.40-$0.80+$1.60-$0.10$0.50M$0.30M
5/11/2023Q1 2023-$2.40-$0.80+$1.60-$0.10$0.50M$0.30M
5/11/2023Q1 2023-$2.40-$0.80+$1.60-$0.10$0.50M$0.30M
5/11/2023Q1 2023-$2.40-$0.80+$1.60-$0.10$0.50M$0.30M
5/11/2023Q1 2023-$2.40-$0.80+$1.60-$0.10$0.50M$0.30M
5/11/2023Q1 2023-$2.40-$0.80+$1.60-$0.10$0.50M$0.30M
5/11/2023Q1 2023-$2.40-$0.80+$1.60-$0.10$0.50M$0.30M
5/11/2023Q1 2023-$2.40-$0.80+$1.60-$0.10$0.50M$0.30M
5/11/2023Q1 2023-$2.40-$0.80+$1.60-$0.10$0.50M$0.30M
5/11/2023Q1 2023-$2.40-$0.80+$1.60-$0.10$0.50M$0.30M
5/11/2023Q1 2023-$2.40-$0.80+$1.60-$0.10$0.50M$0.30M
5/11/2023Q1 2023-$2.40-$0.80+$1.60-$0.10$0.50M$0.30M
5/11/2023Q1 2023-$2.40-$0.80+$1.60-$0.10$0.50M$0.30M
5/11/2023Q1 2023-$2.40-$0.80+$1.60-$0.10$0.50M$0.30M
5/11/2023Q1 2023-$2.40-$0.80+$1.60-$0.10$0.50M$0.30M
5/11/2023Q1 2023-$2.40-$0.80+$1.60-$0.10$0.50M$0.30M
5/11/2023Q1 2023-$2.40-$0.80+$1.60-$0.10$0.50M$0.30M
5/11/2023Q1 2023-$2.40-$0.80+$1.60-$0.10$0.50M$0.30M
5/11/2023Q1 2023-$2.40-$0.80+$1.60-$0.10$0.50M$0.30M
5/11/2023Q1 2023-$2.40-$0.80+$1.60-$0.10$0.50M$0.30M
5/11/2023Q1 2023-$2.40-$0.80+$1.60-$0.10$0.50M$0.30M
5/11/2023Q1 2023-$2.40-$0.80+$1.60-$0.10$0.50M$0.30M
5/11/2023Q1 2023-$2.40-$0.80+$1.60-$0.10$0.50M$0.30M
5/11/2023Q1 2023-$2.40-$0.80+$1.60-$0.10$0.50M$0.30M
5/11/2023Q1 2023-$2.40-$0.80+$1.60-$0.10$0.50M$0.30M
5/11/2023Q1 2023-$2.40-$0.80+$1.60-$0.10$0.50M$0.30M
5/11/2023Q1 2023-$2.40-$0.80+$1.60-$0.10$0.50M$0.30M
5/11/2023Q1 2023-$2.40-$0.80+$1.60-$0.10$0.50M$0.30M
5/11/2023Q1 2023-$2.40-$0.80+$1.60-$0.10$0.50M$0.30M
5/11/2023Q1 2023-$2.40-$0.80+$1.60-$0.10$0.50M$0.30M
The U.S. just rewrote the rules of retirement (Ad)

For decades, Wall Street told retirees to stick with big names, stay diversified, and live off dividends. But Tim Plaehn says those rules no longer apply — and the 2025 trade war is exposing just how fragile that plan really was. Tim just released a video briefing explaining how the global shift is hammering traditional income stocks — and how a few U.S.-focused companies are built to weather the chaos.

Watch the 2025 Trade War dividend protection briefing now
5/11/2023Q1 2023-$2.40-$0.80+$1.60-$0.10$0.50M$0.30M
5/11/2023Q1 2023-$2.40-$0.80+$1.60-$0.10$0.50M$0.30M
5/11/2023Q1 2023-$2.40-$0.80+$1.60-$0.10$0.50M$0.30M
5/11/2023Q1 2023-$2.40-$0.80+$1.60-$0.10$0.50M$0.30M
5/11/2023Q1 2023-$2.40-$0.80+$1.60-$0.10$0.50M$0.30M

OncoCyte Earnings - Frequently Asked Questions

OncoCyte has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 13th, 2025 based off last year's report dates. Learn more on OCX's earnings history.

In the previous quarter, OncoCyte (NASDAQ:OCX) reported $0.48 earnings per share (EPS) to beat the analysts' consensus estimate of ($0.40) by $0.88. Learn more on analysts' earnings estimate vs. OCX's actual earnings.

The conference call for OncoCyte's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for OncoCyte's latest earnings report can be read online.
Read Transcript

OncoCyte (NASDAQ:OCX) has a recorded annual revenue of $1.88 million.

OncoCyte (NASDAQ:OCX) has a recorded net income of -$27.78 million. OCX has generated -$4.40 earnings per share over the last four quarters.

OncoCyte's earnings are expected to grow from ($2.57) per share to ($1.40) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:OCX) was last updated on 4/18/2025 by MarketBeat.com Staff
From Our Partners